Skip to main content

Table 4 miRNAs defined in EVs as a working biomolecule for OA therapy

From: The role of extracellular vesicles in osteoarthritis treatment via microenvironment regulation

EV Source

miRNA

Selected animals model in vivo

Role

Pathway

Effect

Reference

UMSCs

lncRNA H19

SD Rats

Promote chondrocyte migration and matrix secretion and inhibit cell apoptosis and senescence

miR-29b-3p/FOXO3

Promote sustained cartilage repair

[86]

AD-MSCs

miR-100-5p

C57BL/6 mice

Promote the proliferation of chondrocytes, increase the level of chondrocytes autophagy, enhance matrix synthesis, and reduce the expression of metabolic factors

mTOR signaling pathway

Protect articular cartilage from damage and ameliorate gait abnormality

[78]

S-MSCs

miR-140-5p

SD rats

Increase the proliferation and migration of chondrocytes

Wnt signaling pathway

Successfully prevent OA

[73]

S-MSCs

miR-155-5p

BALB/C mice

Promote the proliferation and migration of chondrocytes and inhibit cell apoptosis

Runx2

Prevent OA

[75]

hBM-MSCs

miR-136-5p

C57BL/6 mice

Promote the migration of chondrocytes and inhibit chondrocytes degeneration

Targets ELF3

Prevent traumatic OA

[150]

MSCs

miR-135b

SD rats

Promote chondrocyte proliferation and inhibit cartilage degradation

Sp1

Promote cartilage repair

[81]

hMSCs

miR-206

C57BL/6 mice

Promote chondrocyte proliferation and inhibit chondrocyte apoptosis

KLF3-AS1/miR-206/GIT1 axis

Attenuate chondrocyte injury

[19]